EUR-Lex Access to European Union law
This document is an excerpt from the EUR-Lex website
Document 62020TA0579
Case T-579/20: Judgment of the General Court of 2 March 2022 — Genekam Biotechnology v Commission (Grant agreement concluded under the Seventh Framework Programme for research, technological development and demonstration activities (2007-2013) — Fibrogelnet project — Recovery of an amount receivable — Risk avoidance mechanism — Amount receivable effectively recovered from the Guarantee Fund — Decision establishing a pecuniary obligation and forming an enforceable decision — Article 299 TFEU — Competence of the author of the act — Termination of the applicant’s participation in the project — Eligible costs — Reports and deliverables)
Case T-579/20: Judgment of the General Court of 2 March 2022 — Genekam Biotechnology v Commission (Grant agreement concluded under the Seventh Framework Programme for research, technological development and demonstration activities (2007-2013) — Fibrogelnet project — Recovery of an amount receivable — Risk avoidance mechanism — Amount receivable effectively recovered from the Guarantee Fund — Decision establishing a pecuniary obligation and forming an enforceable decision — Article 299 TFEU — Competence of the author of the act — Termination of the applicant’s participation in the project — Eligible costs — Reports and deliverables)
Case T-579/20: Judgment of the General Court of 2 March 2022 — Genekam Biotechnology v Commission (Grant agreement concluded under the Seventh Framework Programme for research, technological development and demonstration activities (2007-2013) — Fibrogelnet project — Recovery of an amount receivable — Risk avoidance mechanism — Amount receivable effectively recovered from the Guarantee Fund — Decision establishing a pecuniary obligation and forming an enforceable decision — Article 299 TFEU — Competence of the author of the act — Termination of the applicant’s participation in the project — Eligible costs — Reports and deliverables)
OJ C 198, 16.5.2022, p. 37–37
(BG, ES, CS, DA, DE, ET, EL, EN, FR, HR, IT, LV, LT, HU, MT, NL, PL, PT, RO, SK, SL, FI, SV)
OJ C 198, 16.5.2022, p. 29–29
(GA)
- Date of document:
- 02/03/2022
- Date lodged:
- 21/09/2020
- Author:
- General Court
- Form:
- Judicial information
- Authentic language:
- German
- Type of procedure:
- Action for annulment - unfounded
- Link
- Select all documents mentioning this document
- Case affecting:
-
- Related EU case-law document 62020TJ0579
- Instruments cited in case law:
- Link
|
16.5.2022 |
EN |
Official Journal of the European Union |
C 198/37 |
Judgment of the General Court of 2 March 2022 — Genekam Biotechnology v Commission
(Case T-579/20) (1)
(Grant agreement concluded under the Seventh Framework Programme for research, technological development and demonstration activities (2007-2013) - Fibrogelnet project - Recovery of an amount receivable - Risk avoidance mechanism - Amount receivable effectively recovered from the Guarantee Fund - Decision establishing a pecuniary obligation and forming an enforceable decision - Article 299 TFEU - Competence of the author of the act - Termination of the applicant’s participation in the project - Eligible costs - Reports and deliverables)
(2022/C 198/52)
Language of the case: German
Parties
Applicant: Genekam Biotechnology AG (Duisburg, Germany) (represented by: S. Hertwig, lawyer)
Defendant: European Commission (represented by: L. André, J. Estrada de Solà and R. Pethke, acting as Agents)
Re:
Application under Article 263 TFEU for annulment of Commission Decision C(2020) 5548 final of 7 August 2020 establishing a pecuniary obligation and forming an enforceable decision against the applicant for the amount of EUR 119 659,55, together with default interest, arising from the grant that it received in respect of the Fibrogelnet project.
Operative part of the judgment
The Court:
|
1. |
Dismisses the action; |
|
2. |
Orders Genekam Biotechnology AG to pay the costs, including those relating to the proceedings for interim measures. |
